推荐产品
等级
pharmaceutical primary standard
API类
ritonavir
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
mixture
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Ritonavir Related Compounds Mixture USP reference standard suitable for use in specified USP compendial tests and assays.
Also used to prepare system suitability stock, system suitability, and identity solution for impurity analysis by using the liquid chromatography method and UV detector according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare system suitability stock, system suitability, and identity solution for impurity analysis by using the liquid chromatography method and UV detector according to the given below monographs of United States Pharmacopeia (USP):
- Lopinavir and Ritonavir Tablets
- Ritonavir Tablets
- Ritonavir
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
相关产品
产品编号
说明
价格
警示用语：
Warning
危险分类
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Lopinavir and Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 2670-2670 (2013)
Ritonavir
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 37(4), 3912-3912 (2020)
Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 3920-3920 (2013)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门